三级妇产专科医院羊水栓塞13例诊治及文献复习

Abstract
Figure/Table
References
Related Citation (12)

Download: PDF (1036 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To summarize the clinical data of amniotic fluid embolism and to explore the mechanism of amniotic fluid embolism.Methods From March 2011 to November 2018, the symptoms, signs, laboratory examinations, medication treatment, maternal and fetal pregnancy outcomes and prognosis of patients with amniotic fluid embolism during late pregnancy in Beijing Obstetrics and Gynecology Hospital were retrospectively recorded.Results Among the 109401 late pregnancy delivery records in our hospital, there were 13 cases of amniotic fluid embolism, with an incidence of 11.88/100 000, 53.8% (7/13) of pregnant women over 35 years old, 53.8% (7/13) of multipartum, 4 cases of allergic history, 4 cases of high placental risk factors, and 3 cases of pregnancy-induced hypertension. 84.6% (11/13) of the patients had at least one of clinical life-threatening signs (and/or hypotension, hypoxia, DIC), 3 patients had cardiac arrest, 5 patients had DIC, and 9 patients had postpartum hemorrhage (more than 1000 ml) [1100-6000 ml, (2963±406) ml]. Among the 4 patients, 3 were positive for amniotic fluid components from blood samples, 9 were treated with large amounts of vasoactive mediaters for more than 3 hours, and 5 underwent hysterectomy without death.Conclusions Amniotic fluid embolism mainly depends on clinical manifestations for diagnosis. Typical amniotic fluid embolism is a rare and extremely dangerous delivery complication. Timely and accurate diagnosis and well-trained multidisciplinary rapid response team, instant and adequate antiallergic and vasoactive drugs and accurate life support therapy are the key measures to save the lives of patients with amniotic fluid embolism.

Key words： amniotic fluid embolism high risk factors clinical manifestations diagnosis and treatment

Received: 20 April 2019

ZTFLH:

R714.46

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	REN Mingbao
	ZHANG Yawei
	WANG Baojun
	LIU Ye
	and CHEN Guochang

Cite this article:

REN Mingbao,ZHANG Yawei,WANG Baojun等. 13 cases analysis of amniotic fluid embolism in diagnosis and treatment in tertiary obstetric and gynecology hospital[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 704-708.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I8/704

[1]	谢幸,苟文丽.羊水栓塞妇产科学[M].8版. 北京:人民卫生出版社, 2013: 215-218.
[2]	林乐毅,冯烨, 陆芸, 等. 羊水栓塞的发病机制与临床诊治特点[J]. 中华围产医学杂志(电子), 2019,22(4):220-222.
[3]	Society for Maternal-Fetal Medicine (SMFM). Amniotic fluid embolism: diagnosis and management[J]. Am J Obstet Gynecol, 2016, 215(2): B16-B24.
[4]	中华医学会妇产科学分会产科学组. 羊水栓塞临床诊断与处理专家共识(2018)[J].中华妇产科杂志,2018,56(12):831-835.
[5]	Fitzpatrick K E, Tuffnell D, Kurinczuk J, et al. Incidence, risk factors, management and outcomes of amniotic fluid embolism: a population-based cohort and nested case-control study [J]. BJOG, 2016, 123(1): 100-109.
[6]	徐春芳, 王谢桐, 陈延琴. 两次剖宫产术中均发生羊水栓塞1 例[J]. 中国实用妇科与产科杂志,2003,19(5): 318.
[7]	Fineschi V. Editorial: “amniotic fluid embolism: novel biomarkers for future diagnostic investigation and therapy” [J]. Curr Pharm Biotechnol,2014,14(14):1155-1156.
[8]	Kobayashi H. Amniotic fluid embolism: anaphylactic reactions with idiosyncratic adverse response[J]. Obstet Gynecol Surv, 2015, 70(8):511-517.
[9]	Rafael A, Benson M D. Amniotic fluid embolism: then and now[J]. Obstet Med, 2014, 7(1):34-36.
[10]	Fineschi V, Gambassi R, Gherardi M, et al. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase[J]. Int J Legal Med, 1998, 111:238-243.
[11]	Indraccolo U, Battistoni C, Mastrantonio I, et al. Risk factors for fatality in amniotic fluid embolism:a systematic review and analysis of a data pool[J]. J Matern Fetal Neonatal Med, 2018, 31(5): 661-665.
[12]	Tamura N, Farhana M, Oda T, et al. Amniotic fluid embolism: pathophysiology from the perspective of pathology[J]. J Obstet Gynaecol Res,2017,43(4):627-632.
[13]	Pacheco L D, Saade G, Hankins G D, et al. Amniotic fluid embolism: diagnosis and management[J]. Society for Maternal-Fetal Medicine (SMFM).Am J Obstet Gynecol,2016, 215(2): B16-24.
[14]	李连鹏, 戴伟,李桢. 大鼠羊水栓塞模型的法医病理学检验分析[J]. 中国现代医药杂志, 2018, 20(7): 228-230.
[15]	Hession P M, Millward C J, Gottesfeld J E, et al. Amniotic fluid embolism: using the medical staff process to facilitate stream lined care [J]. Perm J,2016,20(4):97-101.
[16]	Balinger K J, Chu Lam M T, Hon H H, et al. Amniotic fluid embolism: despite progress, challenges remain[J]. Curr Opin Obstet Gynecol, 2015,20(8):458-463.
[17]	Sultan P, Seligman K, Carvalho B. Amniotic fluid embolism: update and review[J]. Curr Opin Anaesthesiol, 2016, 29(3): 288-296.
[18]	Fong A, Chau C T, Pan D, et al. Amniotic fluid embolism: antepartum, intrapartum, and demographic factors[J]. J Matern Fetal Neonatal Med,2015,28(7):793-798.